Ochsner Medical Center 1st Hospital in New Orleans to Implant New Defibrillator
NEW ORLEANS -- Ochsner Medical Center is the first and only hospital in New Orleans to offer and implant the Boston Scientific S-ICD® System, the world's first and only subcutaneous implantable cardioverter defibrillator (S-ICD) that provides treatment for patients at risk for sudden cardiac arrest (SCA).
Approximately 850,000 people in the United States are at high risk for sudden cardiac arrest, an abrupt loss of heart function caused by rapid and/or chaotic activity known as ventricular tachycardia or ventricular fibrillation.
The most common risk factor for sudden cardiac arrest is a lower squeezing function, or “ejection fraction,” of the heart’s main pumping chamber. When sudden cardiac arrest occurs, it is usually fatal unless treated immediately – which is where the automatic implanted defibrillator comes in.
Placed under the skin and outside the rib cage, the S-ICD System has two components – the pulse generator and the electrode. Together, they monitor the heart activity for irregular cardiac rhythms, and serve as pathway for shock delivery when necessary. When the device delivers treatment, it causes a jolt through a thin, insulated wire (called a lead) to the side of the chest, restarting the heart without actually touching the heart.
“Other implantable defibrillators have wires that are placed into the heart through blood vessels, and those wires are those devices’ weakest link,” said Daniel Morin, MD, S-ICD implanting cardiologist and Director of Cardiovascular Research at Ochsner Medical Center. “This new device leaves the heart and blood vessels untouched, providing a new exciting solution for both physicians and patients. It’s a life-saving therapy that is minimally invasive and eliminates many of the risks associated with having wires placed through the blood vessels and into the heart.”
The U.S. Food and Drug Administration granted regulatory approval for the S-ICD System in September of 2012. To date, more than 2,000 devices have been implanted in patients around the world.
U.S. News & World Report named Ochsner Medical Center’s Cardiology and Heart Surgery departments among the top 25 across the country in its 2012-13 Best Hospitals rankings. Additionally, Healthgrades has recognized Ochsner with a Five Star rating for providing excellent care in Coronary Interventional Procedures.
Ochsner Health System is southeast Louisiana’s largest non-profit, academic, multi-specialty, healthcare delivery system. Driven by a mission to Serve, Heal, Lead, Educate and Innovate, coordinated clinical and hospital patient care is provided across the region by 10 hospitals, both owned and managed, and more than 40 health centers in Louisiana. Ochsner is the only Louisiana hospital recognized by U.S. News & World Report as a “Best Hospital” across eight specialty categories. Ochsner employs more than 14,000 employees, over 900 physicians in over 90 medical specialties and subspecialties and conducts over 300 clinical research trials annually. Ochsner Health System is proud to be a tobacco